IDBS, located in Guildford, U.K., stated that the purchase of Quantrix will “accelerate development” of E-WorkBook, a product suite for life sciences research that already contains Quantrix Modeler analytics, according to a news release.
Aside from calling it a cash acquisition, financial details of the deal were not disclosed in a news release or in an e-mail to IDBS.
IDBS, a data management and analytics solutions provider to research and development, and healthcare organizations, noted that the acquisition would enable the company to enhance opportunities in the business intelligence realm.
“This transaction allows us to accelerate the introduction of advanced modeling and analytics tools into our solutions for high value areas in pharmaceutical and healthcare informatics, such as translational medicine and preclinical development,” said Neil Kipling, founder and CEO of IDBS, in a news release. “IDBS also recognizes the value of Quantrix technology for a broad range of vertical markets, such as financial services, engineering and manufacturing and will continue to invest in its ongoing development and commercialization.”
As part of the purchase, Quantrix, which has markets in 50 countries and includes financial services, manufacturing and engineering, will continue to be headquartered and operate independently from its base in Portland, Me.
Last year, IDBS acquired InforSense, with both companies since releasing new biomaker and diagnostics applications that combine scientific data management and analytics.
Justin Kern is associate editor at Information Management and can be reached at justin.kern@sourcemedia.com. Follow him on Twitter at @IMJustinKern.
Be the first to comment on this post using the section below.